Related Experiment Video
Updated: Nov 22, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Sirtuins play critical and diverse roles in acute kidney injury
Kevin Peasley1, Takuto Chiba1, Eric Goetzman2
1Department of Pediatrics, Division of Nephrology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Abstract:
Acute kidney injury (AKI) is an extremely common medical affliction affecting both adult and pediatric patients resulting from hypoxic, nephrotoxic, and septic insults affecting approximately 20% of all hospital patients and up to 50% of patients in the intensive care unit. There are currently no therapeutics for patients who suffer AKI. Much recent work has focused on designing and implementing therapeutics for AKI. This review focuses on a family of enzymes known as sirtuins that play critical roles in regulating many cellular and biological functions. There are 7 mammalian sirtuins (SIRT1-7) that play roles in regulating the acylation of a wide variety of pathways. Furthermore, all but one of the mammalian sirtuins have been shown to play critical roles in mediating AKI based on preclinical studies. These diverse enzymes show exciting potential for therapeutic manipulation. This review will focus on the specific roles of each of the investigated sirtuins and the potential for manipulation of the various sirtuins and their effector pathways in mediating kidney injury.
Insights
Sirtuins are enzymes crucial for cellular functions and show promise for treating acute kidney injury (AKI), a common condition lacking current therapies. Research explores manipulating sirtuins (SIRT1-7) to develop new AKI treatments.
Area of Science:
- Biochemistry
- Nephrology
- Molecular Biology
Background:
- Acute kidney injury (AKI) affects ~20% of hospitalized patients, with no current therapeutic options.
- AKI results from hypoxic, nephrotoxic, and septic insults, impacting both adult and pediatric populations.
- Existing research focuses on developing novel therapeutics for AKI.
Purpose of the Study:
- To review the role of sirtuins (silent information regulators) in mediating kidney injury.
- To explore the therapeutic potential of manipulating sirtuins for AKI treatment.
- To examine the specific functions of mammalian sirtuins (SIRT1-7) in kidney pathophysiology.
Main Methods:
- Literature review of preclinical studies on sirtuins and AKI.
- Analysis of the regulatory roles of sirtuins in cellular and biological functions.
- Investigation of sirtuin involvement in various kidney injury pathways.
Main Results:
- Sirtuins are critical regulators of diverse cellular pathways.
- Preclinical studies indicate that most mammalian sirtuins (SIRT1-7) play significant roles in AKI.
- Sirtuins demonstrate potential for therapeutic targeting in kidney injury.
Conclusions:
- Sirtuins represent a promising therapeutic target for acute kidney injury.
- Understanding sirtuin pathways is key to developing novel AKI treatments.
- Further research into sirtuin manipulation could lead to effective AKI therapies.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury VI: Nursing Management

